Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
AstraZeneca
Merck Sharp & Dohme LLC
Alpha-9 Oncology USA Inc.
Fondazione del Piemonte per l'Oncologia
Fred Hutchinson Cancer Center
Mayo Clinic
BioNTech SE
Aminex Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
University of California, Irvine
National Institutes of Health Clinical Center (CC)
Ohio State University
Toray Industries, Inc
Merck Sharp & Dohme LLC
STORM Therapeutics LTD
University Health Network, Toronto
Pfizer
Boehringer Ingelheim
Hanmi Pharmaceutical Company Limited
M.D. Anderson Cancer Center
Psyence Australia Pty Ltd
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
MonTa Biosciences ApS
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Hummingbird Bioscience
University of Wisconsin, Madison
Children's Oncology Group
Ipsen
University of Cincinnati
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Immunocore Ltd
Children's Oncology Group
AstraZeneca
Rutgers, The State University of New Jersey
Diakonos Oncology Corporation
Washington University School of Medicine
University of Florida